Official passes out in Oval Office while standing behind Trump during event

Contributing sentiments towards policy:

61% : The injectable GLP-1 medications will drop to $245 per month for patients on Medicare or Medicaid who utilize them to treat medical conditions such as diabetes that have already been approved by the FDA.
37% : Reporters initially identified the man as Novo Nordisk executive Gordon Finlay however the company later denied that it was him. Reporters who witnessed the incident first-hand said Dr. Mehmet Oz, Administrator for Centers for Medicare & Medicaid Services, helped the executive to the ground, preventing the man from hitting his head.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.